{
  "slug": "cognitivecare",
  "name": "Cognitivecare",
  "description": "CognitiveCare leverages patented and proven AI/ML solutions to accelerate drug discovery, development, and improve health outcomes in the pharma, life sciences, and public health sectors. They provide actionable foresight to manage populations, reduce inefficiencies, and deliver better outcomes by identifying at-risk cohorts.",
  "url": "https://optimly.ai/brand/cognitivecare",
  "websiteUrl": "https://cognitivecare.com/",
  "logoUrl": "https://logo.clearbit.com/cognitivecare.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Drug Discovery & Development Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-20T06:06:03.553Z",
  "verifiedVitals": {
    "website": "https://cognitivecare.com",
    "category": "Health Technology",
    "what_it_does": "CognitiveCare accelerates drug discovery, development, and health outcomes by advancing therapies and powering post-market success. They identify at-risk cohorts to provide actionable foresight for managing populations, reducing inefficiencies, and delivering better outcomes. The company leverages data-driven insights to enhance access, promote effective policies, and improve community outcomes, utilizing AI for applications such as mammography analysis and assessing health risks in expectant mothers.",
    "primary_audience": "Pharma and Life Sciences companies, Public Health organizations, and partners focused on improving maternal and infant well-being, preventing blindness in children, and predicting survival in sepsis cases.",
    "core_product": "CognitiveCare offers AI-powered solutions for health outcomes, including BRICC‑G (Mammogram‑Based Risk Prediction) for broader organ health prediction, and AI-driven tools to assess health risks for expectant mothers and prevent avoidable blindness in children."
  },
  "intentTags": {
    "problemIntents": [
      "Inefficiencies in drug discovery and development",
      "Lack of actionable foresight in population health management",
      "Challenges in enhancing access to public health services",
      "Ineffective public health policies",
      "Poor community health outcomes",
      "Maternal and infant mortality risks",
      "Blindness and myopia in infants and children",
      "Predicting survival in sepsis cases",
      "Metabolic wellness challenges",
      "Limited broader participation in clinical trials",
      "Need for early detection of diseases"
    ],
    "solutionIntents": [
      "Accelerating drug discovery and development",
      "Advancing post-market success for therapies",
      "Identifying at-risk cohorts in healthcare",
      "Effective population health management",
      "Reducing healthcare inefficiencies",
      "Delivering better health outcomes",
      "Providing data-driven insights for public health",
      "Enhancing access to public health services",
      "Promoting effective public health policies",
      "Improving community health outcomes",
      "AI-powered mammography analysis for risk prediction",
      "AI in vision care and ophthalmology",
      "Predictive modeling for infectious diseases",
      "Pharmacoeconomics for metabolic wellness",
      "AI solutions for health risk assessment"
    ],
    "evaluationIntents": [
      "Evaluating AI solutions for healthcare",
      "Assessing data-driven insights for health management",
      "Reviewing predictive analytics for drug development",
      "Comparing solutions for population health management",
      "Seeking partners for public health initiatives",
      "Evaluating AI for early disease detection",
      "Reviewing strategies for clinical trial participation"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1790008251436
}